Table 3 Sensitivity analyses.
ln (PIV) | 28-day mortality | 90-day mortality | ||
|---|---|---|---|---|
HR(95% CI) | P | HR(95% CI) | P | |
Excluding participants with myocardial infarction (N = 3697) | ||||
Model | 1.078(1.024,1.134) | 0.004 | 1.095(1.047,1.145) | < 0.0001 |
ln (PIV) ≤ 6.72 | 0.948(0.855,1.052) | 0.318 | 0.961(0.878,1.051) | 0.382 |
ln (PIV) > 6.72 | 1.071(1.060,1.196) | 0.020 | 1.138(1.034,1.252) | 0.008 |
Excluding participants with cerebrovascular disease (N = 3710) | ||||
Model | 1.056(1.004,1.110) | 0.035 | 1.071(1.024,1.120) | 0.003 |
ln (PIV) ≤ 6.72 | 0.878(0.795,0.969) | 0.010 | 0.889(0.815,0.970) | 0.008 |
ln (PIV) > 6.72 | 1.103(1.008,1.232) | 0.041 | 1.158(1.052,1.275) | 0.003 |
Exclude all individuals with LOS ICU less than 2 days (N = 4335) | ||||
Model | 1.058(1.009,1.108) | 0.019 | 1.077(1.033,1.123) | < 0.0001 |
ln (PIV) ≤ 6.72 | 0.921(0.838,1.012) | 0.086 | 0.930(0.857,1.010) | 0.084 |
ln (PIV) > 6.72 | 1.092(1.006,1.210) | 0.019 | 1.144(1.046,1.250) | 0.003 |